Revenue: The sum of all revenue fields included for a company's operating activities.
Polydex Pharmaceuticals Ltd. (POLXF) had Revenue of $1.49M for the most recently reported fiscal quarter, ending 2023-04-30.
| Income Statement Financials | |
|
Revenue |
$1.49M |
$-0.15M |
|
$1.44M |
|
$0.06M |
|
$1.65M |
|
$-0.15M |
|
-- |
|
$-0.15M |
|
$-0.15M |
|
$-0.15M |
|
$-0.15M |
|
$-0.15M |
|
$-0.15M |
|
$-0.15M |
|
$-0.04M |
|
3.43M |
|
3.43M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$2.76M |
|
$2.80M |
|
$3.23M |
|
$5.99M |
|
$1.06M |
|
$0.00M |
|
$0.08M |
|
$1.15M |
|
$4.83M |
|
$4.85M |
|
$4.85M |
|
3.43M |
|
| Cash Flow Statement Financials | |
$-0.17M |
|
$0.13M |
|
$-0.01M |
|
$0.30M |
|
$0.25M |
|
$-0.05M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.60 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
3.78% |
|
-10.24% |
|
-9.83% |
|
-- |
|
-10.24% |
|
-10.24% |
|
$-0.19M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
1.33 |
|
1.22 |
|
73.64 |
|
-3.17% |
|
-3.16% |
|
-2.55% |
|
-3.16% |
|
$1.41 |
|
$-0.05 |
|
$-0.05 |
|